Scientists Unveil Groundbreaking Therapy Study to Empower Parkinson's Patients with Safe Swallowing - UT Health San Antonio
A groundbreaking study is underway to address the critical issue of swallowing difficulties in Parkinson's patients, a condition affecting up to 80% of those diagnosed. This innovative research, led by Giselle Carnaby, MPH, PhD, aims to revolutionize the lives of individuals with early Parkinson's by strengthening and retraining their swallowing function.
The study, funded by a $1.9 million grant from the United States Department of Defense, is a phase 2, multisite clinical trial. It focuses on a novel treatment program designed to enhance swallowing abilities in Parkinson's patients. This program, called 'SwallowFIT', has already shown promising results in a pilot study, where participants demonstrated significant improvements in swallowing, increased confidence in eating, and a reduction in choking and coughing episodes.
But how does Parkinson's disease impact swallowing? Parkinson's, a neurodegenerative disorder, primarily affects movement due to the breakdown of dopamine-producing neurons in the brain. Along with tremors and muscle stiffness, many patients experience difficulties with the motor control of their mouth and throat muscles, which directly impacts their ability to swallow food and liquids. Swallowing is a complex process involving nearly 30 muscles and a network of brain regions. In Parkinson's, the same neurodegenerative changes that impair walking and speech also disrupt swallowing-related brain pathways, weakening their ability to send clear signals to the involved muscles.
Carnaby explains this communication breakdown as the brain's radio being slightly off the station. While the signal is still detectable, it may not always be clear. This can lead to haphazard messages to the muscles, disrupting the timing and coordination of swallowing. This can result in food or liquid moving more slowly, getting held up, or even entering the airway (aspiration), which can cause persistent coughing and lung infections.
The pilot study, conducted in a small group of Parkinson's patients, tested an intensive swallowing exercise program. Participants, under therapist supervision, practiced targeted swallowing tasks, emphasizing both strength and muscle coordination. The results were encouraging, with participants showing improvements in swallowing, increased confidence in eating, and fewer choking and coughing episodes.
The newly funded, three-year project will expand on this early work with a randomized, double-blind clinical trial. It will enroll approximately 80 participants, aged 30 to 90, diagnosed with Parkinson's disease and active-duty U.S. service members, veterans, or their direct relatives. The study will compare outcomes between individuals receiving the proactive swallowing intervention, 'SwallowFIT', and those undergoing usual care.
The primary recruitment site will be Brooke Army Medical Center, which has a movement disorders clinic with specialized neurologists and neurophysiologists involved in the project. The swallow treatment will be conducted at the university's Health Science Center, which will also serve as a data repository. The research team will track improvements in swallowing and longer-term outcomes at three and six months, including swallowing clinical metrics, aspiration rates, nutritional status, and hospitalizations. Advanced imaging and physiological measures will be used to understand how the therapy alters swallowing efficiency and biomechanics.
The program is built on the principles of neuroplasticity, the brain's ability to adapt and reorganize connections and processes. Study participants will complete structured swallowing exercises twice a week, focusing on strengthening the muscles of the mouth, tongue, and throat, combined with coordination drills to improve the timing and control of the swallowing process. Sessions will continue for six weeks with trained speech-language pathologists at the university, and participants are encouraged to perform daily guided exercises at home.
By improving swallowing, the intervention has the potential to directly reduce the risk of negative swallowing consequences, such as aspiration, which is the leading cause of death in people with Parkinson's. It may also help patients maintain adequate nutrition and hydration, supporting overall health and quality of life. Equally important are the psychological and social benefits, as being able to share a meal with family without fear of coughing and choking can significantly enhance confidence and independence in daily life.
If successful, the trial could lay the groundwork for widespread adoption of proactive swallowing intervention as a standard component of early Parkinson's care. Carnaby envisions future studies that refine and personalize this therapy, possibly combining swallowing exercises with medications or neuromodulation approaches to further enhance outcomes. The goal is to slow or even prevent some of the most debilitating complications of Parkinson's disease.
As the fastest-growing neurodegenerative disease, the findings from this study could have direct implications for nearly 1 million Americans affected by Parkinson's. Carnaby emphasizes that the study's focus is on giving patients more time and a better quality of life, which drives the research team's efforts every day.
